Auto logout in seconds.
Continue Logout
CMS is expanding its Advancing Chronic Care with Effective Scalable Solutions (ACCESS) model to include more health conditions, in today's bite-sized hospital and health industry news from the District of Columbia, Maryland, and Oregon.
- District of Columbia: The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million initiative to develop a patient-facing agentic clinical AI system for cardiovascular care, particularly treatments for heart failure. The program, which is called Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE), aims to create an autonomous tool care teams can use to continuously monitor heart failure patients, provide certain types of care between visits, and escalate issues to clinicians when needed. Teams participating in the program will build a patient-facing AI, a supervisory agentic AI, and scalable deployment plan to produce a scalable clinical AI system for cardiovascular care. "What we are trying to achieve with ADVOCATE is a technology that can serve as a clinician-extender: an autonomous agent smart enough to understand a patient's treatment needs, capable of providing certain care autonomously, and equally capable of engaging the clinical team when needed," said Haider Warraich, ADVOCATE's program manager and a practicing cardiologist. "This work will change how we practice medicine—and it would not happen without ARPA-H driving the vision for the future." (Landi, Fierce Healthcare, 9/11)
- Maryland: CMS is expanding its ACCESS model to include more health conditions. The ACCESS model, which was launched in December, is a 10-year payment program from the Center for Medicare and Medicaid Innovation that provides digital health companies with outcome-aligned payments for using AI and other technology to manage chronic diseases. The program initially focused on diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety. Recently, CMS announced new tracks for heart failure, chronic obstructive pulmonary disease, substance use disorders, and nicotine dependence. The agency also added support for bone, joint, and mobility conditions. The new condition tracks will begin in spring 2027. According to CMS officials, the new tracks significantly expand the model's reach, with an estimated three out of four Medicare beneficiaries now qualifying for at least one ACCESS track. Currently, around 160 organizations are participating in the model, and more will be added over its 10-year duration. Two organizations that recently joined the model are Oura, a smart ring maker, and Counsel Health, an AI-native primary care company. (Landi, Fierce Healthcare, 9/16; Landi, Fierce Healthcare, 9/17)
- Oregon: Providence has received a $1.1 billion philanthropic gift that will help support its flagship Oregon medical center, expand cardiovascular care services, and establish the state's first women's hospital. The gift was given by Phil Knight, the founder of Nike, and his wife Penny. "Penny and I have always believed that real breakthroughs come from people willing to take on the toughest challenges," Knight said. "Providence has shown that kind of ambition in cardiovascular care, and we see the same opportunity to do something truly distinctive for women's health. We're proud to invest in teams that will change what's possible for communities across Oregon and beyond." The couple have been active supporters of the Oregon healthcare community. Over the last decade, they contributed $200 million to Providence Heart Institute. They also pledged $2 billion to their namesake Knight Cancer Institute at Oregon Health & Science University, which allowed the institute to transition to a self-governed entity under the university. (Muoio, Fierce Healthcare, 9/15)
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board
Never miss out on the latest innovative health care content tailored to you.
Benefits Include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
This is for members only. Learn more.
Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board
Never miss out on the latest innovative health care content tailored to you.
Benefits Include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
